Prevalence of suicidal ideation among stroke survivors: A systematic review and meta-analysis

Chen, Xingxing; Zhang, Hua; Xiao, Gui; Lv, Chuanzhu

doi:10.1080/10749357.2020.1846933

Cited by 10 publications

(7 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Suicide attempt is defined as self-injurious behaviors that may have had the intent of causing death. 87 Suicide Ideation, Plans, Attempts, and Suicide After Stroke Suicide ideation is reported by 12.2% of survivors according to a systematic review of 21 studies that included a total of 17 189 participants, 88 although the approaches used to define suicide ideation have uncertain validity (eg, "ever thinking that would be better off dead after a stroke" alongside "recurring thoughts about doing something to kill oneself"). Risk factors are summarized in Table S3.…”

Section: Suicide Behaviors After Strokementioning

confidence: 99%

Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence

Chun

Ford

Kutlubaev

et al. 2022

Stroke

View full text Add to dashboard Cite

Depression and anxiety each affect around 1 in 3 people during the first year after a stroke. Suicide causes the death of about 3 to 4/1000 stroke survivors during the first 5 years. This narrative review describes the best available evidence for the epidemiology of depression, anxiety, and suicide; their prevention; and the treatment of anxiety and depression. We conclude with directions for future research.

show abstract

Section: Suicide Behaviors After Strokementioning

confidence: 99%

Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence

Chun

Ford

Kutlubaev

et al. 2022

Stroke

View full text Add to dashboard Cite

show abstract

Section: Stroke and Suicidal Behaviourmentioning

confidence: 99%

“…Thoughts about death or self-harm seem to be relatively common among stroke survivors compared with the general population, with a recent systematic review of 21 studies that included 17 189 participants reporting a pooled prevalence of 12% [19]. However, there was marked heterogeneity between the studies included in the review, in addition to differences in the time between the stroke and the assessment (from 4 days to 12 months), inconsistency in the definition of suicidal ideation, and varying study designs [19]. Some of these shortcomings were highlighted by a secondary analyses of the AFFINITY trial, which showed that the prevalence of suicidal ideation varied according to the approach used to define its presence: 3% if these thoughts had to be recurrent and present for most of the time compared with 14% if these thoughts had to be present at least once over a period of 52 weeks [20].…”

Section: Stroke and Suicidal Behaviourmentioning

confidence: 99%

Stroke, depression, and self-harm in later life

Almeida

2023

Current Opinion in Psychiatry

View full text Add to dashboard Cite

Purpose of the review To examine recently published results of randomized placebo-controlled trials investigating the clinical effects of selective serotonin reuptake inhibitors on the prevalence of clinically significant symptoms of depression and suicidal ideation after an acute stroke. Recent findings The prevalence of poststroke depression varies markedly according to the approach used to define depression, with recently published data suggesting that about one in every three stroke survivors will experience clinically significant symptoms of depression over a period of 12 months. The proportion of stroke survivors with clinically significant symptoms of depression decreases progressively with time, but in 30% of them symptoms persist or recur over 12 months. Routine daily treatment with 20 mg of fluoxetine for 6 months does not affect the prevalence of depression in this population, nor is it effective at treating or preventing poststroke depressive symptoms. Treatment discontinuation, gastrointestinal adverse effects, seizures and bone fractures are more frequent among stroke survivors treated with antidepressants than placebo. Moreover, current data show that thoughts about death or suicide are more frequent among adults who had a stroke than the general population, although recurring suicidal thoughts are uncommon. Routine daily treatment with 20 mg of fluoxetine for 6 months does not change the proportion of people who disclose suicidal thoughts over a period of 12 months after an acute stroke. Summary Current evidence raises concerns about the efficacy and safety of antidepressants for the management and prevention of poststroke clinically significant symptoms of depression. It is unclear if these findings can be generalized to people with severe strokes or to stroke survivors with moderate to severe major depressive episodes.

show abstract

“…Körperliche Erkrankungen wie bösartige Tumorerkrankungen, Niereninsuffizienz, Schlaganfall und andere neurologische Erkrankungen sind ebenfalls Risikofaktoren für Suizid [24][25][26][27][28]. Zudem sind verschiedene soziodemografische Faktoren wie Unverheiratetsein, Alleineleben und LGBTQI+ (lesbisch, schwul, bise-xuell, trans, queer, intersexuell und weitere Geschlechtsidentitäten) Risikofaktoren für Suizid [29][30][31].…”

Section: Grundbegriffe Und Epidemiologische Grundlagenunclassified

Warum brauchen wir Leitlinien für Suizidprävention?

Reif

Wagner

Wolfersdorf

2021

Bundesgesundheitsbl

View full text Add to dashboard Cite

ZusammenfassungTrotz der Relevanz des Themas Suizidalität und gut bekannter Risikofaktoren gibt es bisher keine deutsche Leitlinie zur Suizidalität im Erwachsenenalter. In diesem Beitrag werden zunächst die Geschichte und die Hintergründe der Arbeit mit Leitlinien beschrieben. Der aktuelle Stand der Leitlinien für psychische Erkrankungen in Deutschland wird dargestellt und auf suizidpräventive Inhalte hin untersucht. Die Notwendigkeit evidenzbasierter Suizidprävention und einer spezifischen Leitlinie zur Suizidprävention bei Erwachsenen wird diskutiert.Nur durch gezielte Suizidpräventionsstrategien und Interventionen für die jeweiligen Risikogruppen und unter Beachtung von Alters- und Geschlechtsspezifität kann für alle Betroffenen eine flächendeckende, gut erreichbare, bedarfs- und versorgungsgerechte, finanzierbare sowie nachhaltige medizinische Versorgung auf einem hohen Niveau sichergestellt werden. Dies gilt für den ambulanten und den stationären Bereich sowie für deren Schnittstellen. Bei Suizidalität handelt es sich um ein diagnoseübergreifendes, in unterschiedlichen Versorgungskontexten auftretendes Syndrom mit komplexem Behandlungsbedarf, weshalb intersektorale und multiprofessionelle Aspekte in einer entsprechenden Leitlinie besonders zu adressieren sind. Wissenschaftliche Evidenz und interdisziplinärer Konsens unter Expertinnen und Experten zum Umgang mit suizidalem Verhalten in der medizinischen Versorgung können dazu beitragen, Morbidität und Mortalität im Zusammenhang mit Suizidalität zu reduzieren. Im August 2021 wurde die Finanzierung einer S3-Leitlinie „Umgang mit Suizidalität“ vom Innovationsfonds des Gemeinsamen Bundesausschusses bewilligt.

show abstract

Prevalence of suicidal ideation among stroke survivors: A systematic review and meta-analysis

Cited by 10 publications

References 60 publications

Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence

Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence

Stroke, depression, and self-harm in later life

Warum brauchen wir Leitlinien für Suizidprävention?

Contact Info

Product

Resources

About